Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge

• Petra van den Doel,

  Affiliation Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Asisa Volz,

  Affiliation Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany

  ⨯
• Jouke M. Roose,

  Affiliation Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Varsha D. Sewbalaksing,

  Affiliation Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Gorben P. Pijlman,

  Affiliation Laboratory of Virology, Wageningen University, Wageningen, The Netherlands

  ⨯
• Ingeborg van Middelkoop,

  Affiliation Laboratory of Virology, Wageningen University, Wageningen, The Netherlands

  ⨯
• Vincent Duiverman,

  Affiliation Erasmus Medical Center Laboratory Animal Science Center (EDC), Rotterdam, The Netherlands

  ⨯
• Eva van de Wetering,

  Affiliation Erasmus Medical Center Laboratory Animal Science Center (EDC), Rotterdam, The Netherlands

  ⨯
• Gerd Sutter,

  Affiliation Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany

  ⨯
• Albert D. M. E. Osterhaus,

  Affiliations Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands, Artemis One Health, Utrecht, The Netherlands

  ⨯
• Byron E. E. Martina

  * E-mail: b.martina@erasmusmc.nl

  Affiliations Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands, Artemis One Health, Utrecht, The Netherlands

  ⨯